ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's unit ties up with Shanghai Henlius Biotech
Dr Reddy's Laboratories has partnered with Shanghai Henlius Biotech to develop and commercialize HLX15, a biosimilar to the cancer drug Darzalex. Henlius will manage development and manufacturing, receiving up to 1.6 million. Dr Reddy's gains exclusive
Announcement as on 06 February 2025

Dr Reddy’s, Zydus, Cipla, Sun can sustain low-double digit EPS growth over medium term: Bino Pathiparampil
Indian pharma companies like Dr Reddy’s, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term. The generic Revlimid opportunity was significant but will end by FY27, affecting profits. While the CDMO industry shows promise,
Announcement as on 24 January 2025

Stocks in news: IndiGo, JSW Steel, Adani Green, Indus Towers, Dr Reddy's, Patanjali Foods
Shares of IndiGo, JSW Steel, DLF and Godrej Consumer will be in focus as the companies will announce their third quarter results later today.
Announcement as on 24 January 2025

Dr Reddy's Labs Q3 Results: Cons PAT rises 2% YoY to Rs 1,413 crore, revenue up 16%
Dr Reddy's Labs Q3 Results: Dr Reddy's Laboratories on Thursday reported a 2% year-on-year growth in its December quarter consolidated net profit at Rs 1,413 crore versus Rs 1,379 crore posted in the year ago period.
Announcement as on 23 January 2025

Stocks in news: Ultratech, Dr Reddy's, HUL, Go Digit, Airtel
FMCG major Hindustan Unilever Ltd (HUL) profit beat the Street estimates as it rose 19% year-on-year (YoY) to Rs 3,001 crore in the third quarter. This was mainly on the back of one-time gain.
Announcement as on 23 January 2025

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 13.14
  • 12Day Average: 13.2
  • 20Day Average: 13.39
  • 50Day Average: 13.95
  • 100Day Average: 13.87
  • 150Day Average: 13.96
  • 200Day Average: 14.06

RDY Indicators & signals

Indicator MACD (12,26,9)

13.27, 13.49, -0.22
Indicator MACD is in negative zone

Indicator ADX (14)

11.11, 31.25, 25
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
17 Fri Apr 2026 13.30 13.29 to 13.59 1.84% 0.83 times
16 Thu Apr 2026 13.06 12.97 to 13.13 0.93% 0.74 times
15 Wed Apr 2026 12.94 12.86 to 13.36 -1.45% 1 times
14 Tue Apr 2026 13.13 13.12 to 13.37 -1.06% 0.97 times
13 Mon Apr 2026 13.27 13.10 to 13.29 -0.3% 0.73 times
10 Fri Apr 2026 13.31 13.31 to 13.60 0.38% 0.7 times
09 Thu Apr 2026 13.26 13.19 to 13.32 0.15% 1.01 times
08 Wed Apr 2026 13.24 12.96 to 13.28 2.24% 1.45 times
07 Tue Apr 2026 12.95 12.83 to 13.05 -1.45% 0.99 times
06 Mon Apr 2026 13.14 13.12 to 13.30 -1.35% 0.59 times
02 Thu Apr 2026 13.32 13.03 to 13.36 -1.11% 1.82 times
01 Wed Apr 2026 13.47 13.43 to 13.66 -2.74% 1.24 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top